These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22494190)

  • 1. Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer.
    Whitmore TE; Peterson A; Holzman T; Eastham A; Amon L; McIntosh M; Ozinsky A; Nelson PS; Martin DB
    J Proteome Res; 2012 May; 11(5):2653-65. PubMed ID: 22494190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
    Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
    Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis.
    Bera R; Chiou CY; Yu MC; Peng JM; He CR; Hsu CY; Huang HL; Ho UY; Lin SM; Lin YJ; Hsieh SY
    Hepatology; 2014 Jun; 59(6):2238-50. PubMed ID: 24470239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostein expression is highly restricted to normal and malignant prostate tissues.
    Kalos M; Askaa J; Hylander BL; Repasky EA; Cai F; Vedvick T; Reed SG; Wright GL; Fanger GR
    Prostate; 2004 Aug; 60(3):246-56. PubMed ID: 15176054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.
    Huang D; Casale GP; Tian J; Wehbi NK; Abrahams NA; Kaleem Z; Smith LM; Johansson SL; Elkahwaji JE; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1371-81. PubMed ID: 17623804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
    Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
    Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
    Lin D; Watahiki A; Bayani J; Zhang F; Liu L; Ling V; Sadar MD; English J; Fazli L; So A; Gout PW; Gleave M; Squire JA; Wang YZ
    Cancer Res; 2008 Jun; 68(11):4352-9. PubMed ID: 18519696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
    Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
    Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.
    Johnson IR; Parkinson-Lawrence EJ; Butler LM; Brooks DA
    Prostate; 2014 May; 74(5):547-60. PubMed ID: 24435746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
    Gan T; Stevens AT; Xiong X; Wen YA; Farmer TN; Li AT; Stevens PD; Golshani S; Weiss HL; Evers BM; Gao T
    Oncogene; 2020 Oct; 39(44):6789-6801. PubMed ID: 32973331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prostate cancer by proteomics using tissue specimens.
    Liu AY; Zhang H; Sorensen CM; Diamond DL
    J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tissue microarrays in prostate cancer biomarker discovery.
    Datta MW; True LD; Nelson PS; Amin MB
    Adv Anat Pathol; 2007 Nov; 14(6):408-18. PubMed ID: 18049130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.